CTP in Biological Technology

PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug

...plying unique technologies, including its patented ctp technology, primarily to develop longer-acting, pr...e billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins...ements. The development of any products using the ctp platform technology could also be affected by a nu...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

... a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary v...e billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins...ements. The development of any products using the ctp platform technology could also be affected by a nu...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

...s as well as certain associated methods. PROLOR's ctp technology is based on a short amino acid sequence...n humans. When attached to a therapeutic protein, ctp extends the time that the protein is active in the...rently pending. We are confident that our growing ctp patent estate will provide excellent protection fo...

Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting

...LOngevity Redefined--reflects our company's unique ctp technology that has been proven to significantly e... a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary v...te billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins...

Modigene to Present at the BIO-Europe Spring(R) 2009 Conference

...GENE Modigene Inc. is a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary versions of already approv...ns that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is current...

Modigene Sets Record Date for Annual Meeting of Shareholders

...GENE Modigene Inc. is a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary versions of already-approv...ns that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is current...

Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

...r other products developed at the company with its ctp technology. ABOUT ctp Modigene's ctp technology was discovered by researchers at Washi...

Modigene to Present at the UBS Global Life Sciences Conference

...p longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta...

Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

...p longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta...

Modigene Announces Closing of $12 Million Financing by Members of The Frost Group

...cid sequence, the carboxyl terminal peptide (CTP). ctp occurs naturally in humans, and when attached to a... These trials also demonstrated that attaching the ctp peptide did not affect the therapeutic activity of...sive license from Washington University for use of ctp with all therapeutic proteins except four fertilit...

Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

...p longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The ctp technology is applicable to virtually all proteins and Modigene is currently developing long-acting versions of human growth hormone, interferon beta ...

Modigene to Present at the Roth 2007 New York Investor Conference

...w.roth.com/main/Page.aspx?PageID=7015 . ABOUT MODIGENE Modigene Inc. (OTC Bulletin Board: MODG) is a biopharmaceutical company applying its patented ctp technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annu...

Interview: Billpoint Founder Jason May on eBay, Open Source

...logy consulting companies that arose in the 1990s. ctp was later acquired by Novell . I left ctp in 1998 to found Billpoint. The experience I gained at numerous ctp clients from established corporations to start-up...

RNA Amplification for Array Analysis

... an optimal ratio of dye-labeled to unlabeled nucleotide for maximal fluorescence. Usually ~200-400 M of dye-labeled ctp is used with 1-3 mM unlabeled NTPs. Biotin-modified nucleotides are incorporated fairly well with T7 RNA ...